Skip to main content
padlock icon - secure page this page is secure

Tuberculosis contact investigation and short-course preventive therapy among young children in Africa

Buy Article:

$22.93 + tax (Refund Policy)

SETTING: The largest cities in Benin, Burkina Faso, Cameroon and Central African Republic.

OBJECTIVE: To demonstrate the feasibility and document the effectiveness of household contact investigation and preventive therapy in resource-limited settings.

DESIGN: Children under 5 years living at home with adults with bacteriologically confirmed pulmonary tuberculosis (TB) were screened using questionnaire, clinical examination, tuberculin skin test and chest X-ray. Children free of active TB were offered preventive treatment with a 3-month rifampicin-isoniazid (3RH) or 6-month isoniazid (6H) regimen in Benin. Children were followed-up monthly during treatment, then quarterly over 1 year. Costs of transportation, phone contacts and chest X-rays were covered.

RESULTS: A total of 1965 children were enrolled, of whom 56 (2.8%) had prevalent TB at inclusion. Among the 1909 children free of TB, 1745 (91%) started preventive therapy, 1642 (94%) of whom completed treatment. Mild adverse reactions, mostly gastrointestinal, were reported in 2% of children. One case of incident TB, possibly due to a late TB infection, was reported after completing the 3RH regimen.

CONCLUSION: Contact investigation and preventive therapy were successfully implemented in these resource-limited urban settings in programmatic conditions with few additional resources. The 3RH regimen is a valuable alternative to 6H for preventing TB.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: TB prevalence; child; isoniazid; latent TB; rifampicin

Document Type: Research Article

Affiliations: 1: International Union Against Tuberculosis and Lung Disease, Paris 2: International Union Against Tuberculosis and Lung Disease, Paris, école Nationale de Formation des Techniciens Supérieurs en Santé Publique et en Surveillance Epidémiologique, Université de Parakou, Parakou 3: National Tuberculosis Program, Cotonou, Benin 4: National Tuberculosis Program, Ouagadougou, Burkina Faso 5: National Tuberculosis Program, Yaoundé, Cameroon 6: Complexe pédiatrique, Bangui, Central African Republic 7: Centre Hospitalier Universitaire Necker-Enfants Malades, Paris, France 8: United Nations Childrens' Fund, New York, NY, USA 9: International Union Against Tuberculosis and Lung Disease, Paris, University of Melbourne and Burnet Institute, Melbourne, Australia 10: Département de Santé publique, Canton de Vaud, Lausanne, Switzerland 11: UMI TransVIHMI, Institut de Recherche pour le Développement, Montpellier, France

Publication date: April 1, 2020

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.

    To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.

    Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more